Quarterly report [Sections 13 or 15(d)]

Net Loss Per Share (Tables)

v3.26.3
Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Summary of Shares Excluded from Calculation of Diluted Net Loss per Share Applicable to Common Stockholders

The following potentially dilutive shares of common stock have not been included in the computation of diluted net income (loss) per share for the three and nine months ended September 30, 2026 and 2025, as the result would be anti-dilutive:

 

 

Three Months Ended September 30,

 

 

Nine months ended September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Options to purchase shares of stock

 

51,238,360

 

 

 

37,853,738

 

 

 

51,238,360

 

 

 

37,853,738

 

Warrants to purchase shares of stock

 

118,651,067

 

 

 

119,591,301

 

 

 

118,651,067

 

 

 

119,591,301

 

Contingently issuable shares (see Note 9):

 

 

 

 

 

 

 

 

 

 

 

Restricted common stock

 

—

 

 

 

1,660,222

 

 

 

—

 

 

 

1,660,222

 

Contingent consideration

 

—

 

 

 

2,489,030

 

 

 

—

 

 

 

2,489,030

 

Total

 

169,889,427

 

 

 

161,594,291

 

 

 

169,889,427

 

 

 

161,594,291